Company page

Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (ticker: CTKB) is a public company based in the United States, specializing in advanced cell analysis technologies. With a market capitalization of approximately $576 million, Cytek is focused on providing innovative solutions for researchers in the life sciences sector. The company's products enhance the understanding of complex biological systems, supporting advancements in various fields, including immunology and cancer research.